Pharma Pac has recalled 540 tablets (six 90-count bottles) of Valsartan (160 mg), a medication used to treat high blood pressure, because a carcinogen impurity was detected in the active ingredient used to manufacture the drug. This recall affects specific repackaged bottles that were distributed to a physician's office. The affected tablets are yellow, capsule-shaped, and are marked with "343" and "HH". If you are taking this medication, you should contact your doctor or pharmacist for a replacement before you stop taking the drug, as stopping blood pressure medication suddenly can be dangerous.
The medication contains an impurity classified as a probable human carcinogen, which may increase the risk of cancer with long-term exposure. No specific injuries or adverse health events have been reported in connection with this specific recall.
Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.